Pay in 4 interest-free payments of $12.00 Learn more
Ships within 48 hours · Estimated delivery Aug 3 - Aug 8
Formula: C21H16F3N3O3
NI-57 was used at 10 µM final concentration in vitro and in cellular assays
The MPC inhibitor UK5099 increases the glucose excursion seen during an intraperitoneal glucose tolerance test in C57BLK mice
a marker of nociception
is a potent and orally active inhibitor of c-Fms tyrosine kinase (M-CSFR
Ledipasvir - CAS# 1256388-51-8 0153 Formula: C21H16F3N3O3Ledipasvir, also known as GS 5885, CAS No. 1256388 51 8, is an inhibitor of the hepatitis C virus NS5A protein and is a drug for the treatment of hepatitis C that was developed by Gilead Sciences. On October 10, 2014 the FDA approved the combination product ledipasvir 90 mg sofosbuvir 400 mg (trade name Harvoni). The ledipasvir sofosbuvir combination is a direct acting antiviral agent that interferes with HCV replication and can be used to treat
US$ 19.99
US$ 10.00
US$ 20.00
US$ 20.00
US$ 18.00